24 May 2013
Keywords: adalat, demonstrates, additional, cv, benefits, bayer, healthcare
Article | 09 April 2007
Bayer HealthCare, part of Germany's Bayer AG, says that data from trials of its long-acting calcium channel blocker Adalat (nifedipine
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
16 April 2007
2 April 2007
23 May 2013
© 2013 thepharmaletter.com